AI Medical Compendium Journal:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Showing 1 to 7 of 7 articles

The challenges of using machine learning models in psychiatric research and clinical practice.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
To understand the complex nature of heterogeneous psychiatric disorders, scientists and clinicians are required to employ a wide range of clinical, endophenotypic, neuroimaging, genomic, and environmental data to understand the biological mechanisms ...

Robotics in psychiatry - Fiction or reality. A reply.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

The long path ahead of robotics in psychiatry.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Robotics in psychiatry - Fiction or reality?

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Bipolar disorder (BD) is a major healthcare and socio-economic challenge. Despite its substantial burden on society, the research activity in BD is much smaller than its economic impact appears to demand. There is a consensus that the accurate identi...

A machine learning approach to risk assessment for alcohol withdrawal syndrome.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
At present, risk assessment for alcohol withdrawal syndrome relies on clinical judgment. Our aim was to develop accurate machine learning tools to predict alcohol withdrawal outcomes at the individual subject level using information easily attainable...

Computational modeling of the monoaminergic neurotransmitter and male neuroendocrine systems in an analysis of therapeutic neuroadaptation to chronic antidepressant.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Second-line depression treatment involves augmentation with one (rarely two) additional drugs, of chronic administration of a selective serotonin reuptake inhibitor (SSRI), which is the first-line depression treatment. Unfortunately, many depressed p...